Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 1997

Infective endocarditis on natural and prosthetic valves

Stanisław Ostrowski, Bożena Dudkiewicz, Alicja Iwaszkiewicz, Ryszard Jaszewski

Med Sci Monit 1997; 3(4): CR511-517 :: ID: 501354


During the years 1986 to 1994, 120 patients with a diagnosis of infectious endocarditis (IE) were treated in our Department. There were 55 females and 65 males with a mean age of 44 years. In this group were both patients who developed IE on their natural valves (group A containing 65 patients) and those patients who had previously undergone valve replacement and developed I.E. on prosthetic valves (group B with 55 patients). A diagnosis of I.E. was bacteriologically confirmed in 91 patients (75.9%) from samples of blood and natural or artificial valves taken intraoperatively. In 80.2% of these confirmed cases the infectious agents were Gram-positive bacteria, in 17.6%; they were Gram-negative bacteria and in 2.2% fungi were found. Among the Gram-positive bacteria the most common were coagulase-negative strains of Staphylococcus. Indications for surgical treatment were established on the basis of clinical state, response to pharmacotherapy, echocardiography and bacteriological investigation. All 65 patients from group A (infections found on natural valves) were treated both pharmacologically and surgically. Of the 55 patients in group B, 49 were re-operated and 6 patients were treated only pharmacologically. Altogether, a total of 114 out of the 20 patients underwent a cardiac surgery procedure - 92 of them with good result. Mortality rate was 19.2 %; (15.4%of group A and 24.5% of group B). Combining patients with both surgical and medical treatment, 97 patients had a successful outcome (80.9% survival).

Keywords: infective endocarditis, prosthetic valves endocarditis, surgical treatment, etiological factors

Add Comment 0 Comments

371 1


01 May 2023 : Editorial  

Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.940911

Med Sci Monit 2023; 29:e940911


In Press

31 May 2023 : Review article  

Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review

Med Sci Monit In Press; DOI: 10.12659/MSM.939919  

30 May 2023 : Clinical Research  

A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...

Med Sci Monit In Press; DOI: 10.12659/MSM.940409  

30 May 2023 : Review article  

A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...

Med Sci Monit In Press; DOI: 10.12659/MSM.940550  

30 May 2023 : Database Analysis  

The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940904  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750